BianoGMP GmbH

📢 I’m excited about the EUROAPI site in Budapest, let me share some details with you. The site lies on nearly twenty hectares in the town itself and is among the core sites of EUROAPI. ☝ We produce over 50 APIs (active pharmaceutical ingredients) and we have here the most numerous R&D centre in addition the global ITS hub. Our pilot plant and other production areas serve several companies with APIs and CDMO activities worldwide. With excellent experts and top researchers & colleagues we ensure the development and production of raw materials in the European Union. ✅ ✅ ✅ With our history over 110 years we work indeed in the cradle of the pharmaceutical industry production.   #EUROAPI #innovation #chemistry #science

The EUROAPI and BianoGMP GmbH teams are excited to participate in #TIDESEurope! 🤝 Come and meet us - booth #417. Our experts will be pleased to introduce you to our #tides and #CDMO capabilities.   👋 See you soon!   #tides #oligonucleotides #peptides

🔑 Open possibilities with EUROAPI at #TIDESEurope The EUROAPI team is thrilled to introduce you to our #CDMO capabilities in API development and manufacturing at TIDES Europe in Hamburg (November 12-14)! 🤝 Stop by our booth #417 to exchange about your projects, the challenges you face and the solutions we can offer.   📧 Feel free to contact us to schedule a meeting: 👉 [email protected] 👉 https://lnkd.in/ebtyCefs See you soon!   #tides #oligonucleotides #peptides #BianoGMP

🔑 Open possibilities with EUROAPI at #TIDESEurope The EUROAPI team is thrilled to introduce you to our #CDMO capabilities in API development and manufacturing at TIDES Europe in Hamburg (November 12-14)! 🤝 Stop by our booth #417 to exchange about your projects, the challenges you face and the solutions we can offer.   📧 Feel free to contact us to schedule a meeting: 👉 [email protected] 👉 https://lnkd.in/ebtyCefs See you soon!   #tides #oligonucleotides #peptides #BianoGMP

Finally arrived in Montreal - I'm looking forward to meeting customers, colleagues and friends at OTS!

Looking forward to participate on the OTS meeting next week! Meet you there to discuss about oligonucleotide GMP manufacturing! https://lnkd.in/ew7mEQ9v

FDA published the final guidance for industry, Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics, as well as accompaniments to the guidance document: 🔊 Guidance Recap Podcast: https://lnkd.in/ey7kKubP 📘 Podcast Transcript: https://lnkd.in/exV3V6sA

See the latest R&D developments from BianoGMP using a new Knauer Synthesizer & Orbitrap Exploris 120 for impurity screening. https://lnkd.in/dwv8ZTuF

Keynote Speaker: Annemieke Aartsma-Rus 20th Annual Meeting of the Oligonucleotide Therapeutics Society PI & Professor of Translational Genetics Dept. of Human Genetics, Leiden University Medical Center Prof. Dr. Aartsma-Rus played an important role in the development of antisense mediated exon skipping for Duchenne muscular dystrophy during her PhD research (2000-2004) at the LUMC, co-founded the Dutch Center for RNA Therapeutics (DCRT), and is a board member of the N-of-1 collaborative (N1C), a global umbrella organization aiming to facilitate development of antisense oligonucleotide therapies for patients with very rare, eligible mutations. OTS was proud to have Dr. Aartsma-Rus as president of the Oligonucleotide Therapeutics Society from 2019-2021. She is currently a co-editor-in-chief for Nucleic Acid Therapeutics, OTS' official journal. Dr. Aartsma-Rus will deliver the keynote presentation at the OTS Annual Meeting on Sunday, October 6th, drawing from her extraordinary insights from decades of groundbreaking research in therapeutic applications. For more information about Prof. Dr. Annemieke Aartsma-Rus, read her bio: https://lnkd.in/gXsgtqD5 Registration for the event is available at the same link. #ots24 #ots #oligomeeting #oligotherapeutics #oligonucleotide #biotechnology #science #research #montreal #pharmaceuticals #networking #keynote #annemiekeaartsmarus

MMM General Assembly From 7 to 8 June 2024, we organised MMM’s first General Assembly in Barcelona. It was a full success, with talks by all MMM members and much opportunity for discussion and exchange! Let’s keep up the good work!